lose weight without semaglutide for Loss: How It Works, Comparisons, and More Retatrutide for weight loss: Study

In 2023, Lilly acquired Versanis, the developer of bimagrumab, which had a study with semaglutide ongoing at that time

Presented for research literature review only McRobie DJ et al

This is slightly alarming because anyone can be deficient without knowing it

Symptom profile of patients with intestinal methanogen overgrowth: A systematic review and Meta-analysis

The EMA PRAC 2024 review found no causal link between licensed GLP-1 receptor agonists and suicidal ideation or self-harm, but this conclusion cannot be directly applied to retatrutide, which has additional glucagon receptor activity and lacks its own long-term safety data